Aralez Pharmaceuticals Inc. (ARZ.TO)


Toronto - Toronto Delayed Price. Currency in CAD
6.50+0.10 (+1.56%)
At close: 3:54 PM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open6.45
Prev Close6.40
Bid6.38 x
Ask6.79 x
Day's Range6.35 - 6.59
52wk Range4.07 - 8.45
1y Target EstN/A
Market Cap424.07M
P/E Ratio (ttm)-3.81
BetaN/A
Volume15,231
Avg Vol (3m)15,675
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • Capital Cube2 days ago

    ETF’s with exposure to Aralez Pharmaceuticals, Inc. : August 25, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Aralez Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to ARZ-CA. Comparing the performance and risk of Aralez Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • ARLZ: YOSPRALA® PDUFA Date is September 14, 2016
    Zacks Small Cap Research16 days ago

    ARLZ: YOSPRALA® PDUFA Date is September 14, 2016

    The financial results for the corresponding periods in 2015 are those of Pozen, Inc., the predecessor to Aralez. The increase was due to an increase in the royalty rate (10%) due to the company from sales of Vimovo® by AstraZeneca, which was offset by a decrease in royalties from Horizon Pharma due to lower net pricing. The $22.7 million in SG&A was an increase of $4.5 million over the same time period in 2015, primarily driven by $6.2 million in commercialization costs incurred in the U.S., $4.7 million of expenses related to the company’s Canadian operation, and $3 million of additional expenses related to the company’s global corporate structure.

  • Capital Cube16 days ago

    ETF’s with exposure to Aralez Pharmaceuticals, Inc. : August 11, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Aralez Pharmaceuticals, Inc. Here are 5 ETF’s with the largest exposure to ARZ-CA. Comparing the performance and risk of Aralez Pharmaceuticals, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)